CUV 1.82% $15.69 clinuvel pharmaceuticals limited

Ann: CLINUVEL Newsletter II - March 2024, page-18

  1. 2,388 Posts.
    lightbulb Created with Sketch. 515
    Fundamentally and technically this stock is a screaming buy imo. Heavy volume going through the past few weeks. Good sign that the stock has bottomed. Combined with the share buy back plan starting, things are looking pretty good here moving forward I reckon
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.